| Molecular biomarkers in glioblastoma: A systematic review and meta-analysis H Sareen, Y Ma, TM Becker, TL Roberts, P de Souza, B Powter International journal of molecular sciences 23 (16), 8835, 2022 | 57 | 2022 |
| Human TERT promoter mutations as a prognostic biomarker in glioma B Powter, SA Jeffreys, H Sareen, A Cooper, D Brungs, J Po, T Roberts, ... Journal of cancer research and clinical oncology 147, 1007-1017, 2021 | 46 | 2021 |
| The role of liquid biopsies in detecting molecular tumor biomarkers in brain cancer patients H Sareen, C Garrett, D Lynch, B Powter, D Brungs, A Cooper, J Po, ... Cancers 12 (7), 1831, 2020 | 40 | 2020 |
| From Pediatric to Adult Brain Cancer: Exploring Histone H3 Mutations in Australian Brain Cancer Patients B Grebstad Tune, H Sareen, B Powter, S Kahana-Edwin, A Cooper, ... Biomedicines 11 (11), 2907, 2023 | 2 | 2023 |
| CRUX, a platform for visualising, exploring and analysing cancer genome cohort data S El-Kamand, JMW Quinn, H Sareen, TM Becker, M Wong-Erasmus, ... NAR Genomics and Bioinformatics 6 (1), lqae003, 2024 | | 2024 |
| From Pediatric to Adult Brain Cancer: Exploring Histone H3 Mutations in Australian Brain Cancer Patients Biomedicine 11 (11), 10.3390/biomedicines11112907, 2023 | | 2023 |
| Molecular biomarkers in Glioblastoma H Sareen UNSW Sydney, 2023 | | 2023 |
| Role of MDM2 SNP309 gene mutation in pterygium: a pilot study H Sareen, P Prasher, S Singh, AK Thukral, AK Kesavan | | |
